116 related articles for article (PubMed ID: 765905)
41. Intravenous, intramuscular, subcutaneous and intranasal administration of LH-FSH-RH: the duration of effect and occurrence of asynchronous pulsatile release of LH and FSH.
Mortimer CH; Besser GM; Hook J; McNeilly AS
Clin Endocrinol (Oxf); 1974 Jan; 3(1):19-25. PubMed ID: 4600809
[No Abstract] [Full Text] [Related]
42. Hypogonadotropic hypogonadism and anosmia (Kallmann's syndrome) associated with a marker chromosome.
Bergstrom RW; Hansen KL; Clare CN; Katz MS
J Androl; 1987; 8(1):55-60. PubMed ID: 3104265
[TBL] [Abstract][Full Text] [Related]
43. [Disappearance of exogenous luteinizing hormone-releasing hormone and pituitary response in man. Comparison between intravenous and intramuscular administrations (author's transl)].
Nagata Y; Nakamura M; Kusuda M
Fukuoka Igaku Zasshi; 1978 Mar; 69(3):103-8. PubMed ID: 350745
[No Abstract] [Full Text] [Related]
44. The plasma gonadotropin response to gonadotropin-releasing hormone in patients with primary hypogonadism.
Donald RA; Espiner EA
J Clin Endocrinol Metab; 1974 Aug; 39(2):364-9. PubMed ID: 4608918
[No Abstract] [Full Text] [Related]
45. Increased glycolysis in immature rat ovaries using endogenous gonadotropins secreted in response to exogenous luteinizing hormone-releasing hormone.
Sashida T; Johnson DC
Proc Soc Exp Biol Med; 1975 Sep; 149(4):884-7. PubMed ID: 1101271
[TBL] [Abstract][Full Text] [Related]
46. FSH and LH response in the rat after intravenous, intracarotid or subcutaneous administration of LH-RH.
Greeley GH; Allen MB; Mahesh VB
Proc Soc Exp Biol Med; 1974 Dec; 147(3):859-62. PubMed ID: 4614271
[No Abstract] [Full Text] [Related]
47. The effects of daily administration of single and multiple injections of gonadotropin-releasing hormone on pituitary and gonadal function in the hypogonadal (hpg) mouse.
Charlton HM; Halpin DM; Iddon C; Rosie R; Levy G; McDowell IF; Megson A; Morris JF; Bramwell A; Speight A; Ward BJ; Broadhead J; Davey-Smith G; Fink G
Endocrinology; 1983 Aug; 113(2):535-44. PubMed ID: 6409585
[No Abstract] [Full Text] [Related]
48. Kallmann's syndrome: clues to clinical diagnosis.
John H; Schmid C
Int J Impot Res; 2000 Apr; 12(2):121-3. PubMed ID: 11052640
[TBL] [Abstract][Full Text] [Related]
49. [Hypogonadotrophic hypogonadism and anosmia: Kallman's syndrome].
Burgueño M; Burrows R; Muzzo S
Rev Chil Pediatr; 1989; 60(3):169-72. PubMed ID: 2485503
[TBL] [Abstract][Full Text] [Related]
50. Differential effect of various doses of mestranol on the release of luteinizing hormone and follicle-stimulating hormone in response to luteinizing hormone-releasing hormone.
Gonzalez-Barcena D; Kastin AJ; Schalch DS; Ponce-r C; Schally AV
Fertil Steril; 1974 May; 25(5):439-42. PubMed ID: 4613579
[No Abstract] [Full Text] [Related]
51. Administration of arginine-vasotocin (AVT) to human subjects.
Coculescu M; Simionescu L; Cristoveanu A; Serbänescu A; Matulevicius V; Grigorescu F; Temeli E
Prog Brain Res; 1979; 52():535-7. PubMed ID: 121475
[No Abstract] [Full Text] [Related]
52. Magnetic resonance imaging of the hypoplasia of the rhinencephalon in a patient with Kallmann's syndrome.
Takeda T; Takasu N; Yamauchi K; Komiya I; Ohtsuka H; Nagasawa Y; Ohara N; Yamada T
Intern Med; 1992 Mar; 31(3):394-6. PubMed ID: 1611194
[TBL] [Abstract][Full Text] [Related]
53. [Hypogonadotropic hypogonadism associated with anosmia (Kallmann's syndrome): report of seven cases and endocrinological functions (author's transl)].
Okuyama A; Itatani H; Mizutani S; Sonoda T
Nihon Hinyokika Gakkai Zasshi; 1978 Dec; 69(12):1654-9. PubMed ID: 370431
[No Abstract] [Full Text] [Related]
54. X-linked syndrome of congenital ichthyosis, hypogonadism, mental retardation and anosmia.
Perrin JC; Idemoto JY; Sotos JF; Maurer WF; Steinberg AG
Birth Defects Orig Artic Ser; 1976; 12(5):267-74. PubMed ID: 182300
[No Abstract] [Full Text] [Related]
55. Animal models for brain and pituitary gonadal disturbances.
Charlton HM; Wood MJ
Prog Brain Res; 1992; 93():321-31; discussion 331-2. PubMed ID: 1480756
[No Abstract] [Full Text] [Related]
56. The effect of luteinizing hormone-releasing hormone in hypogonadotrophic eunuchoidism.
Bremner WJ; Fernando NN; Paulsen CA
Acta Endocrinol (Copenh); 1977 Sep; 86(1):1-14. PubMed ID: 333842
[No Abstract] [Full Text] [Related]
57. Clinical course of long term treatment with intermittent subcutaneous injection of LHRH in combination with GH replacement in a male patient with hypothalamic hypogonadism due to disruption of the pituitary stalk.
Mori T; Murakami Y; Nishiki M; Kato Y
Endocr J; 1998 Apr; 45 Suppl():S155-8. PubMed ID: 9790253
[No Abstract] [Full Text] [Related]
58. [Intermittent small dosage administration of LH-RH in Kallmann syndrome].
Fujieda K; Mikami Y; Nohara Y; Kato K; Fujita J
Horumon To Rinsho; 1983 Jun; 31 Suppl():51-4. PubMed ID: 6413103
[No Abstract] [Full Text] [Related]
59. [Effect of clomiphene citrate on FSH and LH levels in 4 cases of hypogonadism with hyposmia or anosmia].
Bricaire H; Franchimont P; Luton JP; Valcke JC; Charbonnel B
Ann Endocrinol (Paris); 1972; 33(6):622-8. PubMed ID: 4665420
[No Abstract] [Full Text] [Related]
60. Magnetic resonance imaging of the brain in patients with anosmia and hypothalamic hypogonadism (Kallmann's syndrome).
Klingmüller D; Dewes W; Krahe T; Brecht G; Schweikert HU
J Clin Endocrinol Metab; 1987 Sep; 65(3):581-4. PubMed ID: 3114308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
